https://tankie.tube/videos/watch/fe7d339e-55c1-470f-a611-fa2ee84b6913 President Trump has promised high tariffs on the imports of pharmaceuticals into the United States, to compel drugmakers to reshore the manufacturing of drugs to the US. Drug companies in Europe, Japan, and Singapore are particularly vulnerable. They earn their biggest profits in the American market, and charge far higher prices to US patients. Investors are selling shares of the European drug companies, who face a tough choice between falling US sales because of even higher prices, or investing huge capital to set up new manufacturing lines in the US. But another approach is apparent by looking closely at the supply chains for the pharmaceutical industry. Most of the key components for the drugs themselves come from India and China, who already produce at low cost. For many drugs, Western pharma companies simply package and brand the medicines produced by Indian and Chinese firms. Instead of prioritizing the development of a yet another high-cost industry in the United States, policymakers should instead seek to slash drug prices paid by patients and hospitals. Buying directly from drugmakers in India and China would do the same for branded drugs as in off-label and generics. Closing scene, Huangjuewan Interchange, Chongqing Resources and links: API manufacturing landscape excluding IV fluids, 2024 volume in extended units https://qualitymatters.usp.org/over-half-active-pharmaceutical-ingredients-api-prescription-medicines-us-come-india-and-european India and the EU dominate API manufacturing for the most-used ATC-3 therapeutic classes in the U.S. market https://qualitymatters.usp.org/india-and-eu-dominate-api-manufacturing-most-used-atc-3-therapeutic-classes-us-market Geographic concentration of pharmaceutical manufacturing: USP Medicine Supply Map analysis https://qualitymatters.usp.org/geographic-concentration-pharmaceutical-manufacturing U.S. Pharmaceutical Trade Balance and Key Suppliers https://qyobo.com/us-tariffs-plans/ REALITY CHECK: Indian Pharma is a MADE IN CHINA story https://biznewsbyjay.substack.com/p/reality-check-indian-pharma-is-a Study Finds Over 90% of all Generic Drugs Dependent on Imports https://prosperousamerica.org/study-finds-over-90-of-all-generic-drugs-dependent-on-imports/ Skyrocketing Pharmaceutical Imports to the U.S. Endanger National Security https://prosperousamerica.org/skyrocketing-pharmaceutical-imports-to-the-u-s-endanger-national-security/ How pharma became Switzerland’s Achilles heel in US trade talks https://www.swissinfo.ch/eng/drug-pricing/how-pharma-became-switzerlands-achilles-heel-in-us-trade-talks/89792388 Shares in European drug companies hit four-month low as Trump tariffs loom https://www.theguardian.com/business/2025/aug/06/stocks-shares-european-drug-companies-three-month-low-trump-tariffs How Big Pharma Profits Off U.S. Healthcare https://www.statista.com/chart/25920/sales-revenue-of-best-selling-prescription-drugs-by-illness/ AP, Trump to put additional 25% import taxes on India, bringing combined tariffs to 50% https://apnews.com/article/trump-india-russia-oil-tariffs-2db9dc22d7b56624bdceb2e15c134d60 New York Times, India Will Buy Russian Oil Despite Trump’s Threats, Officials Say https://www.nytimes.com/2025/08/02/world/asia/india-russia-oil-trump-threats.html Thu, 09 Apr 2026 10:27:18 GMT https://validator.w3.org/feed/docs/rss2.html PeerTube - https://tankie.tube https://tankie.tube/lazy-static/avatars/3ba3ff73-a8b6-49c9-add8-9653ef090c7f.webp https://tankie.tube/videos/watch/fe7d339e-55c1-470f-a611-fa2ee84b6913 All rights reserved, unless otherwise specified in the terms specified at https://tankie.tube/about and potential licenses granted by each content's rightholder.